BECHTLE AG (BC8.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:BC8 • DE0005158703

34.84 EUR
-1.4 (-3.86%)
Last: Feb 11, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall BC8 gets a fundamental rating of 5 out of 10. We evaluated BC8 against 74 industry peers in the IT Services industry. While BC8 has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, BC8 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • BC8 had positive earnings in the past year.
  • BC8 had a positive operating cash flow in the past year.
  • In the past 5 years BC8 has always been profitable.
  • Each year in the past 5 years BC8 had a positive operating cash flow.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

  • With a Return On Assets value of 5.25%, BC8 perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.97%, BC8 is in line with its industry, outperforming 47.30% of the companies in the same industry.
  • BC8 has a Return On Invested Capital (8.29%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BC8 is significantly below the industry average of 26.55%.
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROIC 8.29%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of BC8 (3.39%) is comparable to the rest of the industry.
  • BC8's Profit Margin has improved in the last couple of years.
  • The Operating Margin of BC8 (4.89%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BC8 has grown nicely.
  • BC8 has a worse Gross Margin (18.07%) than 85.14% of its industry peers.
  • In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BC8 is creating value.
  • Compared to 1 year ago, BC8 has about the same amount of shares outstanding.
  • Compared to 5 years ago, BC8 has about the same amount of shares outstanding.
  • BC8 has a better debt/assets ratio than last year.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 3.97 indicates that BC8 is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.97, BC8 belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
  • BC8 has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
  • BC8's Debt to FCF ratio of 1.84 is fine compared to the rest of the industry. BC8 outperforms 74.32% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that BC8 is not too dependend on debt financing.
  • BC8 has a Debt to Equity ratio of 0.21. This is in the better half of the industry: BC8 outperforms 71.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Altman-Z 3.97
ROIC/WACC1.25
WACC6.62%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • BC8 has a Current Ratio of 1.68. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BC8 (1.68) is better than 75.68% of its industry peers.
  • A Quick Ratio of 1.39 indicates that BC8 should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.39, BC8 is doing good in the industry, outperforming 71.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.39
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • BC8 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
  • Measured over the past 5 years, BC8 shows a small growth in Earnings Per Share. The EPS has been growing by 7.58% on average per year.
  • Looking at the last year, BC8 shows a decrease in Revenue. The Revenue has decreased by -0.50% in the last year.
  • BC8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.25% yearly.
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%

3.2 Future

  • BC8 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.43% yearly.
  • BC8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.51% yearly.
EPS Next Y-5.37%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
EPS Next 5Y9.43%
Revenue Next Year1.7%
Revenue Next 2Y4.13%
Revenue Next 3Y5.02%
Revenue Next 5Y4.51%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 20.37, which indicates a rather expensive current valuation of BC8.
  • BC8's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 28.23, BC8 is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 16.40, BC8 is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BC8 is on the same level as its industry peers.
  • BC8 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.37
Fwd PE 16.4
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BC8's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as BC8.
Industry RankSector Rank
P/FCF 14.63
EV/EBITDA 9.71
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.69
EPS Next 2Y4.36%
EPS Next 3Y6.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • BC8 has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.44, BC8 has a dividend in line with its industry peers.
  • BC8's Dividend Yield is comparable with the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • The dividend of BC8 is nicely growing with an annual growth rate of 16.00%!
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • BC8 pays out 40.98% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.98%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BECHTLE AG

FRA:BC8 (2/11/2026, 5:29:53 PM)

34.84

-1.4 (-3.86%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-14
Earnings (Next)03-20
Inst Owners39.23%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.39B
Revenue(TTM)6.35B
Net Income(TTM)215.25M
Analysts80
Price Target46.41 (33.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP40.98%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.1%
Min EPS beat(2)-5.27%
Max EPS beat(2)9.48%
EPS beat(4)1
Avg EPS beat(4)-1.86%
Min EPS beat(4)-9.37%
Max EPS beat(4)9.48%
EPS beat(8)2
Avg EPS beat(8)-3.08%
EPS beat(12)3
Avg EPS beat(12)-1.94%
EPS beat(16)6
Avg EPS beat(16)-0.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)0.9%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.9%
Revenue beat(8)3
Avg Revenue beat(8)-2.73%
Revenue beat(12)5
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-3.75%
PT rev (1m)1.32%
PT rev (3m)3.5%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)0.14%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.78%
Valuation
Industry RankSector Rank
PE 20.37
Fwd PE 16.4
P/S 0.69
P/FCF 14.63
P/OCF 10.51
P/B 2.24
P/tB 4.99
EV/EBITDA 9.71
EPS(TTM)1.71
EY4.91%
EPS(NY)2.12
Fwd EY6.1%
FCF(TTM)2.38
FCFY6.84%
OCF(TTM)3.32
OCFY9.52%
SpS50.42
BVpS15.57
TBVpS6.98
PEG (NY)N/A
PEG (5Y)2.69
Graham Number24.48
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROCE 11.68%
ROIC 8.29%
ROICexc 10.25%
ROICexgc 20.62%
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
FCFM 4.72%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexgc growth 3Y4.87%
ROICexgc growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Debt/EBITDA 0.86
Cap/Depr 75.08%
Cap/Sales 1.85%
Interest Coverage 13.03
Cash Conversion 89.38%
Profit Quality 139.44%
Current Ratio 1.68
Quick Ratio 1.39
Altman-Z 3.97
F-Score5
WACC6.62%
ROIC/WACC1.25
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
EPS Next Y-5.37%
EPS Next 2Y4.36%
EPS Next 3Y6.37%
EPS Next 5Y9.43%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%
Revenue Next Year1.7%
Revenue Next 2Y4.13%
Revenue Next 3Y5.02%
Revenue Next 5Y4.51%
EBIT growth 1Y-13.29%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year36.78%
EBIT Next 3Y17.89%
EBIT Next 5Y11.24%
FCF growth 1Y-31.78%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y-22.28%
OCF growth 3Y25.19%
OCF growth 5Y24.58%

BECHTLE AG / BC8.DE FAQ

Can you provide the ChartMill fundamental rating for BECHTLE AG?

ChartMill assigns a fundamental rating of 5 / 10 to BC8.DE.


What is the valuation status for BC8 stock?

ChartMill assigns a valuation rating of 3 / 10 to BECHTLE AG (BC8.DE). This can be considered as Overvalued.


How profitable is BECHTLE AG (BC8.DE) stock?

BECHTLE AG (BC8.DE) has a profitability rating of 5 / 10.


What is the valuation of BECHTLE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BECHTLE AG (BC8.DE) is 20.37 and the Price/Book (PB) ratio is 2.24.


Can you provide the financial health for BC8 stock?

The financial health rating of BECHTLE AG (BC8.DE) is 7 / 10.